510(k) K101037
K101037 is an FDA 510(k) premarket notification submitted by Eps Bio Technology Corp. for the device "EG V1 (BL) SELF MONITORING GLUCOSE TEST SYSTEM MODEL: EPS10017". The FDA issued a decision of Substantially Equivalent on May 23, 2011. The device falls under product code LFR (Glucose Dehydrogenase, Glucose), a Class II device regulated under 21 CFR 862.1345. Eps Bio Technology Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 23, 2011
- Date Received
- April 14, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Glucose Dehydrogenase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type